Table 1.
Clinical Evaluation | |
---|---|
Disease control (symptoms and exacerbations) | Clinical Control Questionnaire for COPD
|
Patient’s quality of life | CAT Test |
Assessment of body mass index (BMI) | Both obesity (BMI > 30 kg/m2) and malnutrition (BMI < 18.5 kg/m2) are associated with a worse prognosis in COPD. |
Monitoring the appearance or presence of what it calls “treatable features” associated with COPD | Alpha-1 antitrypsin deficiency, dyspnea, chronic bronchitis, severe emphysema and pulmonary hyperinflation, chronic bronchial infection, bronchiectasis, precapillary pulmonary hypertension, chronic respiratory insufficiency, cachexia. |
Complementary tests | |
Lung function | Forced spirometry |
Determination of blood pressure, heart rate, and oxygen saturation | In the case of chronic respiratory failure (arterial blood gas: PaO2 < 60 mmHg and/or PaCO2 > 45 mmHg), consider continuous home oxygen therapy or non-invasive ventilation. |
Treatment | |
Treatment adherence and evaluation (response and adverse effects) | Follow-up with the TAI questionnaire and record of medication withdrawn from the electronic prescription. |
Inhaler technique review | Every 2 months to check patient’s satisfaction and ensure appropriate. |
Review of vaccination status | Influenza, SARS-CoV-2, pneumococcal, herpes zoster and tetanus, diphtheria, and pertussis (Tdap). |
Health education | |
Nutritional status | |
Recommendation for regular physical activity adapted to the clinical situation | Calculation of the level of physical activity using the brief CGPPAQ-EGPPAQ2 questionnaire (Spanish version of the Brief Physical Activity Assessment Tool) and assessment of sedentary time (hours/day). |
Persistence of active smoking | Address smoking cessation, and if not achieved, refer to the Smoking Cessation Service. |
BMI, body mass index; CAT, COPD assessment test; COPD, chronic obstructive pulmonary disease; mMRC, modified Medical Research Council; PaCO2, partial pressure of arterial carbon dioxide; PaO2, partial pressure of arterial oxygen; TAI, test of adherence to inhalers.